title: Omalizumab, an additional therapy for allergic bronchopulmonary aspergillosis.
authors.affiliation: San Antonio Military Medical Center, San Antonio, Texas. Electronic address: martin.o.evans.mil@mail.mil.
authors.forename: Martin Oman
authors.initials: MO
authors.lastname: Evans
authors.affiliation: San Antonio Military Medical Center, San Antonio, Texas.
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Morris
authors.affiliation: San Antonio Military Medical Center, San Antonio, Texas.
authors.forename: Christopher Albert
authors.initials: CA
authors.lastname: Coop
authors.affiliation: College of Osteopathic Medicine of the Pacific-Northwest, Lebanon, Oregon.
authors.forename: Sara Ellen
authors.initials: SE
authors.lastname: Evans
mesh_terms: D000328:Adult; D018926:Anti-Allergic Agents / Q000627:therapeutic use*; D018927:Anti-Asthmatic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001229:Aspergillosis, Allergic Bronchopulmonary / Q000188:drug therapy* / Q000276:immunology; D001232:Aspergillus fumigatus / Q000276:immunology; D001249:Asthma / Q000188:drug therapy; D005260:Female; D006801:Humans; D000069444:Omalizumab / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D018926:Anti-Allergic Agents; D018927:Anti-Asthmatic Agents; D000069444:Omalizumab